CBS EYE ON THE WORLD WITH JOHN BATCHELOR

FIRST HOUR   

9-915  
Voter Disapproval of Two Presidents. @DanHenninger @WSJOpinion 
https://www.wsj.com/articles/biden-trump-excesses-presidency-approval-democrats-moderates-spending-mandate-11637183588
 

915-930 
Italy Warns of the Virus along the Austrian and Slovenian Frontiers. Lorenzo Fiori, Ansaldo Foundation, Milano, Italia
https://www.nytimes.com/2021/11/15/world/europe/europe-vaccine.html
 

930-945 
The Las Vegas Taxicab Airport Availability Index for the Recovery. @GeneMarks @Guardian @PhllyInquirer November 
Demand for design services moderates but remains strong
https://www.aia.org/press-releases/6454837-demand-for-design-services-moderates-but-r
 

945-1000 
#SmallBusinessAmerica: Saturday 27— the Big Test! @GeneMarks  @Guardian @PhillyInquirer
Supply chain troubles make Small Business Saturday a crucial test of holiday sales
https://www.inquirer.com/business/holidays-shopping-inventory-supply-shortages-thanksgiving-20211116.html

SECOND HOUR   

10-1015 
Weaponizing Turkish Airlines for Lukashenko. @AykanErdemir @FDD
 https://www.fdd.org/analysis/2021/11/16/swift-trans-atlantic-action/
 

1015-1030 
Scott Morrison Embraces Australia's High-Quality Coal. Scott Mayman @CBSNews Brisbane, Australia
https://www.newsweek.com/australias-prime-minister-earns-f-home-abroad-cop26-bungling-opinion-1649856
 
1030-1045 
Hubble Methuselah.  Bob Zimmerman, BehindtheBlack.com
https://behindtheblack.com/behind-the-black/points-of-information/hubble-operations-contract-extended-to-2026-even-as-engineers-work-to-fix-it/
 

1045-1100     
New Zealand's Rocket Lab to Virginia.  Bob Zimmerman, BehindtheBlack.com
https://behindtheblack.com/behind-the-black/points-of-information/nasa-expected-to-finally-certify-rocket-labs-virginia-launchpad-by-end-of-year/

THIRD HOUR  

1100-1200 
1/8, 2/8, 3/8, 4/8  A Shot to Save the World: The Inside Story of the Life-or-Death Race for a COVID-19 Vaccine, by Gregory Zuckerman   @GZuckerman
-  Hardcover – October 26, 2021
https://www.amazon.com/Shot-Save-World-Life-Death/dp/059342039X/ref=tmm_hrd_swatch_0?_encoding=UTF8&qid=&sr=
Few were ready when a mysterious respiratory illness emerged in Wuhan, China, in January 2020. Politicians, government officials, business leaders, and public-health professionals were unprepared for the most devastating pandemic in a century. Many of the world’s biggest drug-and vaccine-makers were slow to react or couldn’t muster an effective response.
 
It was up to a small group of unlikely and untested scientists and executives to save civilization. A French businessman dismissed by many as a fabulist. A Turkish immigrant with little virus experience. A quirky Midwesterner obsessed with insect cells. A Boston scientist employing questionable techniques. A British scientist despised by his peers. Far from the limelight, each had spent years developing innovative vaccine approaches. Their work was met with scepticism and scorn. By 2020, these individuals had little proof of progress. Yet they and their colleagues wanted to be the ones to stop the virus that was holding the world hostage. They scrambled to turn their life’s work into life-saving vaccines in a matter of months, each gunning to make the big breakthrough—and to beat each other for the glory that a vaccine guaranteed.
 

FOURTH HOUR  

12-100 AM     
5/8, 6/8, 7/8, 8/8  A Shot to Save the World: The Inside Story of the Life-or-Death Race for a COVID-19 Vaccine, by Gregory Zuckerman   @GZuckerman 
-  Hardcover – October 26, 2021
https://www.amazon.com/Shot-Save-World-Life-Death/dp/059342039X/ref=tmm_hrd_swatch_0?_encoding=UTF8&qid=&sr=
Few were ready when a mysterious respiratory illness emerged in Wuhan, China, in January 2020. Politicians, government officials, business leaders, and public-health professionals were unprepared for the most devastating pandemic in a century. Many of the world’s biggest drug-and vaccine-makers were slow to react or couldn’t muster an effective response.
 
It was up to a small group of unlikely and untested scientists and executives to save civilization. A French businessman dismissed by many as a fabulist. A Turkish immigrant with little virus experience. A quirky Midwesterner obsessed with insect cells. A Boston scientist employing questionable techniques. A British scientist despised by his peers. Far from the limelight, each had spent years developing innovative vaccine approaches. Their work was met with scepticism and scorn. By 2020, these individuals had little proof of progress. Yet they and their colleagues wanted to be the ones to stop the virus that was holding the world hostage. They scrambled to turn their life’s work into life-saving vaccines in a matter of months, each gunning to make the big breakthrough—and to beat each other for the glory that a vaccine guaranteed.
..  ..  ..